Common Contracts
5 similar Credit Agreement contracts by Avinger Inc, PDL Biopharma, Inc., Adma Biologics, Inc.
CREDIT AGREEMENTCredit Agreement • October 11th, 2017 • Adma Biologics, Inc. • Biological products, (no disgnostic substances)
This Credit Agreement dated as of October 10, 2017 (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”), is made among ADMA Biologics, Inc., a Delaware corporation (“ADMA Biologics”), ADMA Plasma Biologics, Inc., a Delaware corporation (“ADMA Plasma”) and ADMA Bio Centers Georgia Inc., a Delaware corporation (“ADMA Bio Centers”), ADMA BioManufacturing, LLC, a Delaware limited liability company (“ADMA BioManufacturing” and together with ADMA Biologics, ADMA Plasma and ADMA Bio Centers, individually and collectively, jointly and severally, the “Borrower”), Marathon Healthcare Finance Fund, L.P., as the lender (the “Lender”), and Wilmington Trust, National Association, not individually, but as the Agent (as defined below).
CREDIT AGREEMENT dated as of April 18, 2013 among AVINGER, INC. as the Borrower, PDL BIOPHARMA, INC., as the Lender, and PDL BIOPHARMA, INC., as the AgentCredit Agreement • December 30th, 2014 • Avinger Inc • Surgical & medical instruments & apparatus
This Credit Agreement dated as of April 18, 2013, (as amended, restated or otherwise modified from time to time, this “Agreement”) is made among AVINGER, INC., a Delaware corporation (the “Borrower”), PDL BIOPHARMA, INC. (the “Lender”), and PDL BIOPHARMA, INC., not individually, but as the Agent (as defined below).
CREDIT AGREEMENT dated as of April 18, 2013 among AVINGER, INC. as the Borrower, PDL BIOPHARMA, INC., as the Lender, and PDL BIOPHARMA, INC., as the AgentCredit Agreement • November 6th, 2014 • Avinger Inc • Surgical & medical instruments & apparatus
This Credit Agreement dated as of April 18, 2013, (as amended, restated or otherwise modified from time to time, this “Agreement”) is made among AVINGER, INC., a Delaware corporation (the “Borrower”), PDL BIOPHARMA, INC. (the “Lender”), and PDL BIOPHARMA, INC., not individually, but as the Agent (as defined below).
CREDIT AGREEMENTCredit Agreement • August 8th, 2013 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances)
This Credit Agreement dated as of April 18, 2013, (as amended, restated or otherwise modified from time to time, this “Agreement”) is made among AVINGER, INC., a Delaware corporation (the “Borrower”), PDL BIOPHARMA, INC. (the “Lender”), and PDL BIOPHARMA, INC., not individually, but as the Agent (as defined below).
CREDIT AGREEMENTCredit Agreement • March 1st, 2013 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances)
This Compliance Certificate (this “Certificate”) is given by WELLSTAT DIAGNOSTICS, LLC, a Delaware limited liability company (“Borrower”), pursuant to that certain Credit Agreement dated as of November 2, 2012 (the “Credit Agreement”; capitalized terms used and not defined herein shall have the meaning set forth in the Credit Agreement), between Borrower and PDL BIOPHARMA, INC., as Lender and Agent (“Agent”).
